Executive Summary
Summary Hainan Shuangcheng Pharmaceuticals Co Ltd (Shuangcheng Pharma) is a pharmaceutical company that develops, manufactures and markets generic peptide drugs, finished dosages and active pharmaceutical ingredients. Its products include thymalfasin, thymopetin, somatostatin, levocarnitine, famotidine, ligustrazine phosphate, adenosine cyclophosphate, sodium ferulate, ganciclovir, pantoprazole sodium, omeprazole sodium, calcium folinate, inosine, aciclovir, clindamycin hydrochloride and azithromycin, among others. Shuangcheng Pharma sells its products throughout China. The company operates its manufacturing facility in Haikou, China. Shuangcheng Pharma is headquartered in Haikou, China. Hainan Shuangcheng Pharmaceuticals Co Ltd (002693)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. - Business Description-A brief description of the company's operations. - Key Employees-A list of the key executives of the company. - Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors-A list of the key competitors of the company. - Key Recent Developments-A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Read More
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 Hainan Shuangcheng Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11 Asset Purchase 11 Hainan Shuangcheng Acquires Selling Right of Tauro-ursodesoxycholic Acid 11 Equity Offering 12 Hainan Shuangcheng Pharma Withdraws Private Placement of shares for USD146 Million 12 Hainan Shuangcheng Pharma Completes IPO For USD 95 Million 13 Acquisition 14 Hainan Shuangcheng Pharma Sells 46% Stake in Hangzhou-Based Biotechnology Company for USD39.5 Million 14 Hainan Shuangcheng Pharma to Acquire 74.9% Stake in Lyomark Pharma and Bendalis for up to USD33 Million 15 Hainan Shuangcheng Pharma to Acquire 56% Stake in Hangzhou Ausia BioTech for USD154 Million 16 Hainan Shuangcheng Pharmaceuticals Co Ltd-Key Competitors 17 Hainan Shuangcheng Pharmaceuticals Co Ltd-Key Employees 18 Hainan Shuangcheng Pharmaceuticals Co Ltd-Locations And Subsidiaries 19 Head Office 19 Appendix 20 Methodology 20 About GlobalData 20 Contact Us 20 Disclaimer 20
List of Tables Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Hainan Shuangcheng Pharmaceuticals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8 Hainan Shuangcheng Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9 Hainan Shuangcheng Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10 Hainan Shuangcheng Acquires Selling Right of Tauro-ursodesoxycholic Acid 11 Hainan Shuangcheng Pharma Withdraws Private Placement of shares for USD146 Million 12 Hainan Shuangcheng Pharma Completes IPO For USD 95 Million 13 Hainan Shuangcheng Pharma Sells 46% Stake in Hangzhou-Based Biotechnology Company for USD39.5 Million 14 Hainan Shuangcheng Pharma to Acquire 74.9% Stake in Lyomark Pharma and Bendalis for up to USD33 Million 15 Hainan Shuangcheng Pharma to Acquire 56% Stake in Hangzhou Ausia BioTech for USD154 Million 16 Hainan Shuangcheng Pharmaceuticals Co Ltd, Key Competitors 17 Hainan Shuangcheng Pharmaceuticals Co Ltd, Key Employees 18
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Hainan Shuangcheng Pharmaceuticals Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
|
Agriculture and Animal Care
Automotive, Transportation and Warehousing
Banking Financial Services and Insurance
Consumer Products and Retail
Defense and Security
Education and Recruitment
Energy and Utilities
Food, Beverage and Tobacco
Healthcare
Manufacturing and Construction
Media and Entertainment
Metal, Mining and Chemicals
Public Sector and Administration
Technology and Telecom
